Institutional Biosafety CommitteeName of Committee: Institutional Biosafety Committee
Mission Statement: The IBC and the Department of Occupational Health and Safety (OH&S) have been charged with the planning and implementation of the campus Safety Programs. Membership is appointed by the Vice President for Research and is comprised of the Chair and members representing the community and a variety of university interests as well as members who are knowledgeable in microbiology and infectious disease, chemistry, occupational health and safety, recombinant DNA technology, animal experimentation, public health, law, and UAB policy. The Committee is structured to ensure that collective experience and expertise exists to evaluate the occupational risks associated with the wide variety of research conducted at UAB. The Committee has the authority to impose disciplinary measures in cases where there is violation of UAB's established practices and procedures.
Chair Name: Dr. Suzanne Michalek
Committee Contact Person: Donna S. Williamson, Director of Research Safety Committees
Phone number: 934-4752
Top 3 FAQ
1. What projects need to be reviewed and approved by the UAB IBC?
NIH mandates that all non-exempt recombinant projects, regardless of funding agency, be reviewed and approved by the IBC prior to initiation. At UAB, all projects that involve the use of Risk Group/Biosafety 2 or higher agents must also be reviewed and approved by the IBC prior to work with these agents. Visit CDC for safety level information for various agents.
2. Is my recombinant work exempt or non-exempt?
3. What are my responsibilities under the NIH Guidelines as a PI?
This NIH brochure outlines your responsibilities as a PI. Basically, PIs are responsible for full compliance with the NIH Guidelines during the conduct of research involving recombinant or synthetic nucleic acid molecules. Your responsibilities start well in advance of the actual work and cover all aspects of the proposed project. Most nonexempt work performed at UAB requires IBC review and approval prior to project initiation. After approval, any modifications must be communicated to and approved by the IBC. You must immediately report any significant problems pertaining to the operation and implementation of containment practices and procedures, violations of the NIH Guidelines, or any significant research-related accidents or illnesses to the IBC, NIH OBA, and other Institutional authorities as appropriate.
Did You Know?
Forms or Guides
Project Registration Form
Appendix A: IBC Roles & Responsibilities
Applying for a Grant
Biosafety in Microbiological and Biomedical Laboratories
Animal experiments covered under NIH guidelines
Is my project exempt from the NIH Guidelines?
The currently scheduled meeting dates for 2014 are:
December 29 (may possibly combine Nov & Dec meetings on Dec 8)